New device spots dangerous IV leaks before nurses can
NCT ID NCT06758011
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a device called ivWatch® that monitors IV sites during chemotherapy. If the medication starts leaking out of the vein, the device alerts the nurse early, before visible signs appear. Over 2,400 cancer patients took part to see if the device could prevent tissue damage from these leaks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTRAVASATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a breathing exercise and music tame cancer treatment fatigue?
- Can a Finger-Prick replace the lab draw? a device puts accuracy to the test
- Exercise may boost immunotherapy in kidney cancer
- Scientists test novel way to detect pancreatic cancer from biopsy fluid
- Can exercise help cancer patients? new study aims to find out
- Simple exercises ease chemo nerve damage in new study